open-burger-menu
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
📈 NEW Report: Abortions, Tax Funding UP at Planned Parenthood >>
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

close-panel
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Sort 1464 results by:

Filter results further
Filter Applied. Clear All

Latest Posts

October 6, 2026 A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Inside The Government Decision That Opened Up Abortion Pill Floodgates Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review
Latest Research / Life & the Law

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

This paper critically analyzes the FDA's 2021 REMS Review leading to the removal of the in-person dispensing requirement for mifepristone.

Zachary Sluzala,… Ingrid Skop,…
October 6, 2026
Inside The Government Decision That Opened Up Abortion Pill Floodgates
Latest Research / Abortion Drugs

Inside The Government Decision That Opened Up Abortion Pill Floodgates

The decision "fell well short" of the FDA's standards.

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Latest Research / Life & the Law

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

This paper critically analyzes the FDA's 2021 literature review that served as the basis for its controversial decision to remove…

Ingrid Skop,…
October 6, 2026
Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement
Latest Research / General

Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement

A new peer-reviewed article on the Food and Drug Administration’s (FDA) 2021 complete review of mifepristone’s Risk Evaluation and Mitigation…

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Abortion Reporting: Kentucky (2025)
Latest Research / Abortion

Abortion Reporting: Kentucky (2025)

In 2025, five brick-and-mortar abortions were reported in Kentucky by the state’s Cabinet for Health and Family Services. The data…

Elyse Gaitan Mia Steupert,…
October 5, 2026
New Video: Child with High Risk Leukemia Recovers after Adult Stem Cell Transplant
Fetal Tissue, Stem Cells & Bioethics

New Video: Child with High Risk Leukemia Recovers after Adult Stem Cell Transplant

Today the Charlotte Lozier Institute released its newest Stem Cell Research Facts video telling the story of 10-year-old Devon Weaver of Arizona. For many years, Devon’s parents and doctors were mystified as to why he struggled with everyday activities such as sitting up by himself and feeding himself, and why at four years old his bone density was that of a two-year-old. Finally, when Devon was eight, he was diagnosed with Juvenile Myelomonocytic Leukemia (JMML) – a high-risk leukemia with a slim survival rate of 5 to 10 percent in children.

charlotte-lozier-institute Charlotte Lozier Institute
January 20, 2016
Assisted Suicide at the Polls: Risks & Rewards Associated with Voting to Legalize Assisted Suicide vs. Maintaining the Status Quo
End of Life

Assisted Suicide at the Polls: Risks & Rewards Associated with Voting to Legalize Assisted Suicide vs. Maintaining the Status Quo

By Jacqueline H. Abernathy, Ph.D. This academic paper analyzes the significance of a legislator’s position in favor of assisted suicide.  In particular, the paper looks at the risk associated with support for legalization of assisted suicide on subsequent re-election.  This original work comes from the Department of Social Sciences at Tarleton State University, written by Dr. Jacqueline C. Harvey, a political science faculty member. This version of the paper is a conference abstract that was presented at the 2016 Southern Political Science Association Conference.  The full version of the paper will be published in an appropriate academic journal at a later date.

charlotte-lozier-institute Charlotte Lozier Institute
January 19, 2016
Charlotte Lozier Institute Adds Three New Women Associate Scholars
General

Charlotte Lozier Institute Adds Three New Women Associate Scholars

charlotte-lozier-institute Charlotte Lozier Institute
January 18, 2016
Sanctity of Human Life Sunday
Life & the Law

Sanctity of Human Life Sunday

Today, January 17, is recognized as Sanctity of Human Life Sunday (SOHLS) by Americans, especially Christians, across the country. The first national Sanctity of Human Life Day was designated as on January 22, 1984, via a proclamation issued by then-President Ronald Reagan.

Moira Gaul, M.P.H.
January 17, 2016
PRESS RELEASE: Lozier Scholar Submits Amicus Brief in Little Sisters Case
Maternal & Public Health

PRESS RELEASE: Lozier Scholar Submits Amicus Brief in Little Sisters Case

These cases represent a challenge against the Obamacare contraception mandate and its impact on the religious freedom of the Little Sisters of the Poor and other religious nonprofits.  The religious nonprofit organizations are arguing that the so-called “accommodation” crafted by the Obama Administration violates religious freedom protections secured by the federal Religious Freedom Restoration Act (RFRA).

Michael J. New,…
January 12, 2016
Decline in Female Contraceptive Clients Continues at Planned Parenthood
Maternal & Public Health

Decline in Female Contraceptive Clients Continues at Planned Parenthood

Of all the Planned Parenthood data being looked at today as a result of release of the agency’s annual report, one of the more significant is the continued decline in its client total for reversible contraceptive methods (excluding services like sterilization and emergency contraceptive kits).

Charles A. “Chuck”…
January 4, 2016
China’s Two-Child Policy Would Continue Crimes against Women and Children
Life & the Law

China’s Two-Child Policy Would Continue Crimes against Women and Children

"First the [Chinese Communist Party] would kill any baby after one. Now they will kill any baby after two.” – Chen Guangcheng, Chinese human rights advocate (Oct. 29, 2015)

A woman with long dark hair and glasses smiles at the camera. She is wearing a dark blazer, dangling pearl earrings, and a necklace, set against a neutral gray background—her look exudes confidence and professionalism in science. Genevieve Plaster, M.A.
December 21, 2015
CLI Vice Pres. Dr. Prentice on Human Embryo Genetic Manipulation: “Modest but Meaningful Protection”
Life & the Law

CLI Vice Pres. Dr. Prentice on Human Embryo Genetic Manipulation: “Modest but Meaningful Protection”

On December 17, 2015, Townhall published an op-ed by CLI Vice President Dr. David Prentice on the only new pro-life item in the federal Omnibus funding bill. Rep. Robert Aderholt (R-Ala.) proposed language to the bill to prevent the approval of the creation or use of genetically-manipulated human embryos in a clinical setting.

David Prentice, Ph.D.
December 17, 2015

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image